November 5, 2007 - Siemens Medical Solutions Diagnostics today signed an agreement with B·R·A·H·M·S Aktiengesellschaft for the rights to develop, produce and distribute a Procalcitonin assay used to assist with the early diagnosis of patients at risk for progression to severe sepsis.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now